Agenus Inc
NASDAQ:AGEN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Agenus Inc
NASDAQ:AGEN
|
US |
|
A
|
Aptose Biosciences Inc
NASDAQ:APTO
|
CA |
|
K
|
Knowledge Atlas Technology JSC Ltd
HKEX:2513
|
CN |
|
N
|
Nokia Oyj
F:NOA3
|
FI |
|
S
|
Sun Communities Inc
F:SCZ
|
US |
|
T
|
Tertiary Minerals PLC
SWB:TMU
|
UK |
|
Genmab A/S
CSE:GMAB
|
DK |
|
Peet Ltd
ASX:PPC
|
AU |
|
Nomura Research Institute Ltd
OTC:NRILY
|
JP |
|
Becton Dickinson and Co
NYSE:BDX
|
US |
|
Petroleo Brasileiro SA Petrobras
BOVESPA:PETR4
|
BR |
|
M
|
McCormick & Company Inc
XBER:MCX
|
US |
|
U
|
United Internet AG
F:UTDI
|
DE |
|
N
|
Northstar Gold Corp
CNSX:NSG
|
CA |
|
Servcorp Ltd
ASX:SRV
|
AU |
|
P
|
Poolbeg Pharma PLC
OTC:POLBF
|
UK |
|
Daetwyler Holding AG
F:31D1
|
CH |
|
Compania de Minas Buenaventura SAA
F:MBU
|
PE |
Bankruptcy Probability
Agenus Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Agenus Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Agenus Inc
NASDAQ:AGEN
|
254.2m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
465B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
212.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
124.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
73B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
47.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Agenus Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Agenus Inc has total debt of 154m USD. This includes both short-term (0 USD) and long-term (154m USD) debt.
You can find a full breakdown on its Balance Sheet.
